SECURITIES COMPLIANCE | 2026-08-03

SEC Stays Nasdaq $5 Million Delisting Rule: California

On July 29, 2026, the SEC's Office of the Secretary notified Nasdaq that notices of intention to petition for review of the staff's July 22 delegated-authority approval of the exchange's new $5 million Market Value of Listed Securities continued listing standard had been received — automatically staying the approval under Rule 431(e) of the Commission's Rules of Practice and suspending, for now, a no-cure-period delisting regime that had put California's microcap biotech and technology issuers on a path to potential trading suspensions as early as September 2026.

By Anatolii Trembach, Esq. (California State Bar No. 349304; LL.M., USC Gould School of Law; admitted to the U.S. Court of International Trade), Trembach Law Firm, APC · Published

On July 29, 2026, one week after the U.S. Securities and Exchange Commission's Division of Trading and Markets approved Nasdaq's new $5 million Market Value of Listed Securities continued listing rule under delegated authority, the SEC's Office of the Secretary notified Nasdaq that notices of intent

Contact Trembach Law Firm at (818) 514-7680 for a confidential consultation.

Trembach Law Firm | 27001 Agoura Road, Suite 350, Calabasas, CA 91301